Xarostat-ASP 10 Capsule is a combination pharmaceutical formulation containing Rosuvastatin 10 mg and Aspirin 75 mg, indicated for the management of cardiovascular risk in patients with hyperlipidemia and a history or risk of thrombotic events. Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) and total cholesterol levels by inhibiting cholesterol biosynthesis in the liver, thereby reducing atherosclerotic plaque formation. Aspirin, an antiplatelet agent, irreversibly inhibits cyclooxygenase-1 (COX-1), leading to decreased thromboxane A2 production and subsequent inhibition of platelet aggregation, which helps prevent arterial thrombosis. The combination of these agents provides a dual mechanism to reduce cardiovascular morbidity and mortality in patients at high risk of myocardial infarction, stroke, or other atherothrombotic complications. Xarostat-ASP 10 Capsule is typically prescribed as part of a comprehensive treatment plan including lifestyle modification and regular monitoring of lipid profiles and bleeding risk. Caution is advised in patients with active bleeding, peptic ulcer disease, or hypersensitivity to aspirin or statins. Regular liver function tests and assessment for muscle-related side effects are recommended during therapy. This medication should be used under medical supervision to optimize cardiovascular outcomes.